ArticleAnesthesia and pain medicine2026
Effect of milrinone-terlipressin infusion on blood loss and portal pressure during hepatic resection: a randomized controlled trial.
Article in Anesthesia and pain medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLow central venous pressure (CVP) and Pringle maneuver are commonly employed strategies to reduce bleeding during hepatic resection. Milrinone and terlipressin lower hepatic venous pressure and portal venous pressure (PVP), thereby reducing the risk of bleeding. This study compared the intraoperative blood loss between a combined infusion of milrinone and terlipressin, and terlipressin alone in patients undergoing elective hepatic resection.
methodsA total of 36 patients were randomized to the Milrinone and terlipressin or Terlipressin groups, who received infusions starting 30 min before the beginning of liver resection until the end of the surgery. The primary objective was to determine differences in blood loss between the two groups.
resultsThirty-four patients (17 in each group) were assessed by stratification into major and minor hepatic resections. The median (1Q, 3Q) intraoperative blood loss (in ml) was lower in Milrinone and terlipressin group than in Terlipressin group (570 [329, 880] vs. 824 [750, 1,146]; P = 0.046). In minor resections, milrinone and terlipressin had lower blood loss than terlipressin (373 [273, 556] vs. 798 [725, 1,230]; P = 0.015). There is no difference between the two groups in blood loss during major hepatic resection. The decreases in PVP and CVP at 30 min post-infusion were significant in the Milrinone and terlipressin group (P = 0.002 and P = 0.027, respectively).
conclusionsThe combination of milrinone and terlipressin significantly reduces intraoperative blood loss, especially during minor hepatic resections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.